Press update on World Congress of Cardi...( Save yourself time at the registration...)

(Date:5/20/2013)... Medicare Part D seniors in plans with preferred ... access to pharmacies and other benefits, according to a ... the Pharmaceutical Care Management Association (PCMA). More than 40% ... in plans with preferred networks. , “Seniors like the ... with preferred pharmacy networks,” said PCMA President and CEO ...

(Date:5/20/2013)... A new Benefits of Pharmacy Home Delivery report ... MedEx Pack announced. The new report offers ... order to provide useful details for those who are contemplating ... MedEx Direct owner and pharmacist said, “One of the biggest ... like the MedEx Pack, patients can receive their own pre-filled ...

(Date:5/20/2013)... new report suggests that improved health care and significant ... up the age-old relationship between physicians and drug company ... unnecessary prescription drugs. , This system, which has been ... by keeping them up to date on new medications, ... get patients started on the newest drugs, as well ...

(Date:5/20/2013)... GA (PRWEB) May 20, 2013 ... nominations for this year’s prestigious Information Security Executive® ... , Awards include the Information Security Executive® ... which recognize executives who have made a positive ... protection, regulatory compliance, privacy and information security; and ...

(Date:5/20/2013)... 20, 2013 Selexis SA, a serial ... and cell line development for scale-up and manufacturing of ... will present data on the Company’s core technology at ... Conference, May 20 - 23 at the Hyatt Regency ... co-founder and scientific advisory board member, Nicolas Mermod, PhD, ...

Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2 Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2 Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2 Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3 Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2 Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3 Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2 Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3

[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices [0] Benefits of Pharmacy Home Delivery Report Published by MedEx Direct [0] Breakup of physician, drug company relationship could improve health care, cut cost [0] T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 [0] Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering

(Date:5/20/2013)... , May 20, 2013 AbbVie (NYSE: ... of a Phase 3 clinical study called SONAR ... the effects of the investigational compound atrasentan - when ... kidney disease in patients with stage 2 to ... diabetes. SONAR is a large, multinational, double-blind, placebo-controlled ...

(Date:5/19/2013)... May 20, 2013 Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...

(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...

Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4 Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2

[0] AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy [0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak [0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm

Cached News:

AACR establishes new lectureship in honor of Dr. Jane C. Wright Study shows light therapy to effectively treat mood disorders, including SAD Carnegie Mellon researchers open window into the ability of humans to recognize faces BI-RADS lexicon for ultrasound useful for differentiating benign from malignant solid masses

Community care tops medical care at preventing heart disease in black Americans American Thoracic Society Journal news tips for March 2005 (second issue)Other highlights in the March 16 JNCI Antiretroviral therapy may prevent excess risk of some cancers in people with HIV